Terns Pharmaceuticals (TERN) Change in Account Payables (2020 - 2023)
Terns Pharmaceuticals (TERN) has disclosed Change in Account Payables for 4 consecutive years, with -$810000.0 as the latest value for Q4 2023.
- For the quarter ending Q4 2023, Change in Account Payables fell 71.97% year-over-year to -$810000.0, compared with a TTM value of $1.1 million through Dec 2023, up 259.14%, and an annual FY2024 reading of -$367000.0, down 131.94% over the prior year.
- Change in Account Payables was -$810000.0 for Q4 2023 at Terns Pharmaceuticals, up from -$2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.8 million in Q2 2023 and bottomed at -$2.2 million in Q3 2023.
- Average Change in Account Payables over 4 years is $63000.0, with a median of -$175500.0 recorded in 2020.
- The sharpest move saw Change in Account Payables surged 1586.67% in 2021, then plummeted 356.02% in 2023.
- Year by year, Change in Account Payables stood at $30000.0 in 2020, then soared by 1586.67% to $506000.0 in 2021, then crashed by 193.08% to -$471000.0 in 2022, then plummeted by 71.97% to -$810000.0 in 2023.
- Business Quant data shows Change in Account Payables for TERN at -$810000.0 in Q4 2023, -$2.2 million in Q3 2023, and $2.8 million in Q2 2023.